18F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism

被引:31
|
作者
Pretet, Valentin [1 ]
Rotania, Marianela [1 ,2 ]
Helali, Mehdi [1 ]
Ignat, Mihaela [3 ]
Vix, Michel [3 ]
Imperiale, Alessio [1 ,4 ,5 ]
机构
[1] ICANS Univ Hosp Strasbourg, Nucl Med & Mol Imaging, F-67033 Strasbourg, France
[2] Inst Oulton, Mol & Nucl Med, X5000 JJS, Cordoba, Argentina
[3] Univ Strasbourg, IRCAD IHU, Gen Digest & Endocrine Surg, F-67033 Strasbourg, France
[4] Univ Strasbourg, Fac Med, F-67033 Strasbourg, France
[5] CNRS Unistra, IPHC, Mol Imaging DRHIM, UMR 7178, F-67033 Strasbourg, France
关键词
F-18-Fluorocholine PET; 4D contrast-enhanced CT; primary hyperparathyroidism; parathyroid; adenoma; ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; COMPUTED-TOMOGRAPHY; LOCALIZATION; SCINTIGRAPHY; MANAGEMENT; SPECT/CT; SURGERY; UPDATE;
D O I
10.3390/jcm9062005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present retrospective study evaluates the diagnostic value of integrated(18)F-Fluorocholine positron emission tomography/four-dimensional contrast-enhanced computed tomography (F-18-FCH PET/4D-CT) as second-line imaging in preoperative work-up of primary hyperparathyroidism (pHPT), and compares(18)F-FCH PET with 4D-CT. Patients with pHPT and negative/discordant first-line imaging addressed for integrated(18)F-FCH PET/4D-CT were retrospectively selected. Sensitivity and detection rate (DR%) of(18)F-FCH PET/CT, 4D-CT, and PET/4D-CT were calculated according to the per patient and per lesion analyses, and afterwards compared. Histology associated with a decrease more than 50% of perioperative parathyroid hormone (PTH) blood level was used as a gold standard. Persistent high serum PTH and calcium levels during a 6-month follow-up was considered as presence of pHPT in both operated and non-operated patients. 50 patients (55 glands) were included. 44/50 patients (88%) were surgically treated. On a per patient analysis, sensitivity was 93%, 80%, and 95%, and DR% was 82%, 68%, and 84%, respectively for PET/CT, 4D-CT, and PET/4D-CT. PET/CT was more sensitive than 4D-CT (p= 0.046). PET/4D-CT performed better than 4D-CT (p= 0.013) but was equivalent to PET/CT alone. On a per gland analysis, sensitivity PET/CT, 4D-CT, and PET/4D-CT was 88%, 66%, and 92%, and DR% was 79%, 57%, and 83%, respectively. PET/CT and PET/4D-CT were more sensitive than 4D-CT alone (p= 0.01,p< 0.001, respectively). However, PET/CT and PET/4D-CT performed similarly. In conclusion,F-18-FCH PET provides better identification of hyperfunctioning parathyroids than 4D-CT and the combination of both did not significantly improve diagnostic sensitivity. Further investigations involving larger populations are necessary to define the role of(18)F-FCH PET/4D-CT as a "one-stop shop" second-line imaging in preoperative work-up of pHPT, especially considering the additional patient radiation exposure due to multi-phase CT.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Will 18F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging?
    Luca Giovanella
    Lorenzo Bacigalupo
    Giorgio Treglia
    Arnoldo Piccardo
    Endocrine, 2021, 71 : 285 - 297
  • [42] Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study
    Broos, Wouter A. M.
    Wondergem, Maurits
    Knol, Remco J. J.
    van der Zant, Friso M.
    EJNMMI RESEARCH, 2019, 9 (1)
  • [43] 18F-Fluorocholine PET/CT in Recurrent Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03) : 20N - 20N
  • [44] 18F-Fluorocholine PET/CT Finding of a Vertebral Hemangioma
    Savelli, Giordano
    Perotti, Valentina
    Rosso, Edoardo
    Pizzocaro, Claudio
    Magnaldi, Silvia
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (08) : E390 - E391
  • [45] Superior sensitivity of 18F-fluorocholine: PET localization in primary hyperparathyroidism
    Graves, Claire E.
    Hope, Thomas A.
    Kim, Jina
    Pampaloni, Miguel H.
    Kluijfhout, Wouter
    Seib, Carolyn D.
    Gosnell, Jessica E.
    Shen, Wen T.
    Roman, Sanziana A.
    Sosa, Julie A.
    Duh, Quan-Yang
    Suh, Insoo
    SURGERY, 2022, 171 (01) : 47 - 54
  • [46] False-Positive Results in 18F-Fluorocholine PET/CT for a Thymoma in Workup of a Hereditary Primary Hyperparathyroidism
    Bricaire, Leopoldine
    Richard, Capucine
    Gauthe, Mathieu
    Cochand-Priollet, Beatrix
    Gaujoux, Sebastien
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (05) : E151 - E153
  • [47] Comparability of Early Dynamic and Conventional Static Imaging With 18F-Fluorocholine PET/CT in a Patient With Primary Hyperparathyroidism
    Prabhu, Meghana
    Kumari, Garima
    Damle, Nishikant Avinash
    Arora, Geetanjali
    Tripathi, Madhavi
    Bal, Chandrasekhar
    Kumar, Praveen
    Kumar, Rajeev
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (11) : E400 - E401
  • [48] Brain Nocardiosis Defined by 18F-Fluorocholine PET/CT
    Garcia Vicente, Ana Maria
    Noriega Alvarez, Edel
    Gonzalez Rodriguez, Jose Carlos
    Soriano Castrejon, Angel Maria
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : 327 - 329
  • [49] Pre-operative 18F-Fluorocholine PET/4D-MRI in primary hyperparathyroidism
    Kaseb, A.
    Aymard, S.
    Poterszman, N.
    Hubele, F.
    Vix, M.
    Imperiale, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S173 - S173
  • [50] 18F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism
    Alessio Imperiale
    David Taïeb
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 654 - 657